Faculty Development Competitive Research Grant Program, Nazarbayev University, Kazakhstan [110119FD4537]

Link to this page

Faculty Development Competitive Research Grant Program, Nazarbayev University, Kazakhstan [110119FD4537]

Authors

Publications

Dinuclear silver(I) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes

Savić, Nada D.; Petković, Branka B.; Vojnović, Sandra; Mojicević, Marija; Wadepohl, Hubert; Olaifa, Kayode; Marsili, Enrico; Nikodinović-Runić, Jasmina; Djuran, Milos; Glišić, Biljana

(Royal Soc Chemistry, Cambridge, 2020)

TY  - JOUR
AU  - Savić, Nada D.
AU  - Petković, Branka B.
AU  - Vojnović, Sandra
AU  - Mojicević, Marija
AU  - Wadepohl, Hubert
AU  - Olaifa, Kayode
AU  - Marsili, Enrico
AU  - Nikodinović-Runić, Jasmina
AU  - Djuran, Milos
AU  - Glišić, Biljana
PY  - 2020
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1313
AB  - New dinuclear silver(i) complexes withN,N ',N '',N '''-tetrakis(2-pyridylmethyl)-1,4,8,11-tetraazacyclotetradecane (tpmc), [Ag-2(NO3)(tpmc)]NO3 center dot 1.7H(2)O (1), [Ag-2(CF3SO3)(2)(tpmc)] (2), and [Ag-2(tpmc)](BF4)(2) (3) were synthesized and characterized by NMR (H-1 and(13)C), IR and UV- Vis spectroscopy, cyclic voltammetry and molar conductivity measurements. The molecular structures of the complexes were determined by single-crystal X-ray diffraction analysis. The spectroscopic and crystallographic data showed that the structure of the complexes strongly depends on the nature of the counteranion of silver(i) salt used for their synthesis. The antimicrobial activity of complexes1-3was examined against Gram-positive and Gram-negative bacteria and different species of unicellular fungus Candida spp. The ability of these complexes to inhibit the formation of Candida biofilms and to eradicate the already formed biofilms was tested in the standard microtiter plate-based assay. In addition, a bioelectrochemical testing of the antimicrobial activity of complex 1 against early biofilm was also performed. The obtained results indicated that complexes 1-3 showed increased activity toward Gram-negative bacteria and Candida spp. and could inhibit the formation of biofilms. In most cases, these complexes had positive selectivity indices and showed similar or even better activity with respect to the clinically used silver(i) sulfadiazine (AgSD). The values of the binding constants for complexes 1-3 to bovine serum albumin (BSA) were found to be high enough to indicate their binding to this biomolecule, but not so high as to prevent their release upon arrival at the target site. Moreover, the positive values of partition coefficients for these complexes indicated their ability to be transported through the cell membrane. Once inside the cell, complexes 1-3 could induce the formation of the reactive oxygen species (ROS) in C. albicanscells and/or interact with DNA. Taken together, silver(i) complexes with the tpmc ligand could be considered as novel antimicrobial compounds with favourable pharmacological properties, being safer than AgSD.
PB  - Royal Soc Chemistry, Cambridge
T2  - Dalton Transactions
T1  - Dinuclear silver(I) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes
EP  - 10894
IS  - 31
SP  - 10880
VL  - 49
DO  - 10.1039/d0dt01272f
ER  - 
@article{
author = "Savić, Nada D. and Petković, Branka B. and Vojnović, Sandra and Mojicević, Marija and Wadepohl, Hubert and Olaifa, Kayode and Marsili, Enrico and Nikodinović-Runić, Jasmina and Djuran, Milos and Glišić, Biljana",
year = "2020",
abstract = "New dinuclear silver(i) complexes withN,N ',N '',N '''-tetrakis(2-pyridylmethyl)-1,4,8,11-tetraazacyclotetradecane (tpmc), [Ag-2(NO3)(tpmc)]NO3 center dot 1.7H(2)O (1), [Ag-2(CF3SO3)(2)(tpmc)] (2), and [Ag-2(tpmc)](BF4)(2) (3) were synthesized and characterized by NMR (H-1 and(13)C), IR and UV- Vis spectroscopy, cyclic voltammetry and molar conductivity measurements. The molecular structures of the complexes were determined by single-crystal X-ray diffraction analysis. The spectroscopic and crystallographic data showed that the structure of the complexes strongly depends on the nature of the counteranion of silver(i) salt used for their synthesis. The antimicrobial activity of complexes1-3was examined against Gram-positive and Gram-negative bacteria and different species of unicellular fungus Candida spp. The ability of these complexes to inhibit the formation of Candida biofilms and to eradicate the already formed biofilms was tested in the standard microtiter plate-based assay. In addition, a bioelectrochemical testing of the antimicrobial activity of complex 1 against early biofilm was also performed. The obtained results indicated that complexes 1-3 showed increased activity toward Gram-negative bacteria and Candida spp. and could inhibit the formation of biofilms. In most cases, these complexes had positive selectivity indices and showed similar or even better activity with respect to the clinically used silver(i) sulfadiazine (AgSD). The values of the binding constants for complexes 1-3 to bovine serum albumin (BSA) were found to be high enough to indicate their binding to this biomolecule, but not so high as to prevent their release upon arrival at the target site. Moreover, the positive values of partition coefficients for these complexes indicated their ability to be transported through the cell membrane. Once inside the cell, complexes 1-3 could induce the formation of the reactive oxygen species (ROS) in C. albicanscells and/or interact with DNA. Taken together, silver(i) complexes with the tpmc ligand could be considered as novel antimicrobial compounds with favourable pharmacological properties, being safer than AgSD.",
publisher = "Royal Soc Chemistry, Cambridge",
journal = "Dalton Transactions",
title = "Dinuclear silver(I) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes",
pages = "10894-10880",
number = "31",
volume = "49",
doi = "10.1039/d0dt01272f"
}
Savić, N. D., Petković, B. B., Vojnović, S., Mojicević, M., Wadepohl, H., Olaifa, K., Marsili, E., Nikodinović-Runić, J., Djuran, M.,& Glišić, B.. (2020). Dinuclear silver(I) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes. in Dalton Transactions
Royal Soc Chemistry, Cambridge., 49(31), 10880-10894.
https://doi.org/10.1039/d0dt01272f
Savić ND, Petković BB, Vojnović S, Mojicević M, Wadepohl H, Olaifa K, Marsili E, Nikodinović-Runić J, Djuran M, Glišić B. Dinuclear silver(I) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes. in Dalton Transactions. 2020;49(31):10880-10894.
doi:10.1039/d0dt01272f .
Savić, Nada D., Petković, Branka B., Vojnović, Sandra, Mojicević, Marija, Wadepohl, Hubert, Olaifa, Kayode, Marsili, Enrico, Nikodinović-Runić, Jasmina, Djuran, Milos, Glišić, Biljana, "Dinuclear silver(I) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes" in Dalton Transactions, 49, no. 31 (2020):10880-10894,
https://doi.org/10.1039/d0dt01272f . .
17
17